|

Multiple Sclerosis Clinical Trials in Arlington, TX

14 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)Phase 2<1 mi
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 112 mi
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Phase 312 mi
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 YearsPhase 218 mi
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)Phase 318 mi
NARCOMS Registry: A Multiple Sclerosis Registry—18 mi
TSC Biosample Repository and Natural History Database—18 mi
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—18 mi
Ocrelizumab Discontinuation in Relapsing Multiple SclerosisPhase 418 mi
Study of COYA 302 for the Treatment of ALSPhase 218 mi
Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current StimulationN/A26 mi
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple SclerosisPhase 331 mi
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisPhase 331 mi
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)Phase 333 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.